Figure 5. Immunofluorescence staining of GBM cells after
treatment. A , A172 cells after treatment in four conditions: control
(no drug or peptide), TMZ (100 μM), FITC-αCT1 (100 μM), and combination
of 100 μM TMZ and 100 μM FITC-αCT1. B , BT169 cells after
treatment in four conditions. C , U87 cells after treatment in
four conditions. Blue, DAPI; Green, FITC- αCT1; Red, N-terminal Cx43;
Gray, Phalloidin.